Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes
Autor: | Luana Chiquetto Paracatu, Darlene A. Monlish, Zev J. Greenberg, Daniel A.C. Fisher, Matthew J. Walter, Stephen T. Oh, Laura G. Schuettpelz |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Experimental hematology. 110 |
ISSN: | 1873-2399 |
Popis: | Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders, the pathogenesis of which involves enhanced immune signaling that promotes or selects for mutant hematopoietic stem and progenitor cells (HSPCs). In particular, toll-like receptor (TLR) expression and signaling are enhanced in MDS, and their inhibition is an attractive therapeutic strategy. Although prior studies have reported increased expression of TLR2 and its binding partners TLR1 and TLR6 in the CD34 |
Databáze: | OpenAIRE |
Externí odkaz: |